The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

The Food and Drug Administration has introduced a new AI tool that could expedite the review and approval process for medical ...